United Therapeutics Jumps 8.31% as Oil Slips to $97
United Therapeutics shares surged 8.31% on Monday, ranking third among Russell 1000 gainers as WTI crude fell to $97 per barrel and the S&P 500 slid 0.5%. The biotech stock outperformed broader losses in the Dow Jones Industrial Average and Nasdaq 100 during the session.
1. Market Performance
United Therapeutics closed up 8.31% on Monday, making it the third-best performer in the Russell 1000 index’s list of top gainers. The stock’s advance outpaced major indexes that registered declines, marking a significant one-day move for the biotech name.
2. Macro Market Context
Crude oil prices eased to $97 per barrel for WTI and $98.31 for Brent, contributing to a broader market pullback. The S&P 500 fell 0.5%, the Dow dropped 0.8% and the Nasdaq 100 dipped 0.1% in a session where only technology and energy sectors posted gains.